Article
Suppression of the malignant phenotype of melanoma cells by anti-oncogene ribozymes.
The Journal of investigative dermatology - 1 Feb 1996
Ohta Y, Kijima H, Kashani-Sabet M, Scanlon K J
Abstract excerpt
The activation of signal transduction pathways by mutation or overexpression of cellular oncogenes has been associated with neoplastic transformation. In this study, we addressed the therapeutic potential of ribozymes targeted against the activated H-ras oncogene as well as against the nuclear proto-oncogenes c-fos and c-myc in the FEM human melanoma cell line containing a H-ras mutation. FEM cells transfected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
